Aberdeen Group’s RXO RXO Stock Holding History

Aberdeen Group’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,636	Closed	-$327K	–	929
2023 Q1	$327K	Buy	+16,636	New	+$319K	﹤0.01%	865

Other funds holding RXO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aberdeen Group's RXO Position: Q2 2023 in Review

Aberdeen Group sold out of RXO (RXO) in Q2 2023, closing a stake of 16,636 shares — an estimated $327K sold.

Aberdeen Group first reported a position in RXO in Q1 2023 and held it in 1 quarter. The position peaked at $327K in Q1 2023. 276 funds tracked by Wall St. Rank hold RXO as of Q2 2023.

Aberdeen Group reported no remaining RXO position as of Q2 2023 after selling out during the quarter.
Aberdeen Group sold 16,636 RXO shares in Q2 2023, an estimated $327K.
Aberdeen Group first reported a position in RXO in Q1 2023 and held it in 1 quarter.
Aberdeen Group's RXO position peaked at $327K in Q1 2023.
276 funds tracked by Wall St. Rank held RXO as of Q2 2023.

Based on Aberdeen Group's 13F filing for Q2 2023, filed 4 Aug 2023.